Integrated Wealth Concepts LLC reduced its DuPont de Nemours stake by 65.3% in Q2, selling 13,713 shares. DuPont reported strong Q2 earnings beating EPS expectations with a 4% revenue increase.
Chemours, DuPont, and Corteva agreed to a $455 million settlement with North Carolina over PFAS litigation at the Fayetteville Works facility. Chemours will bear 50% of the cost, paid over 15 years, a
Tidal Investments LLC reduced its stake in DuPont de Nemours by selling 53,359 shares. DuPont exceeded quarterly earnings expectations with $1.88 EPS, maintaining a Moderate Buy rating.
HB Wealth Management LLC reduced its DuPont de Nemours stake by 70.1% in Q2. The chemical firm reported strong earnings but cut dividends while other institutions increased holdings.
Baird Financial Group Inc. reduced its DuPont de Nemours stake by 66.3% in Q2, selling 187,448 shares. DuPont recently beat EPS estimates, maintaining a Moderate Buy rating from analysts despite the i
Arizona State Retirement System reduced its DuPont de Nemours stake by 65.6% in Q2, retaining $5.31 million. Meanwhile, DuPont reported strong quarterly earnings beating estimates with analysts mainta
Corteva, DuPont, and Chemours agreed to a $455 million settlement with North Carolina over PFAS contamination claims at the Fayetteville Works site. Corteva's portion is approximately $66 million, alo
KeyBanc initiated Corteva stock at Sector Weight, highlighting spin-off concerns and a $455 million PFAS settlement despite recognizing strong fundamentals.
Empirical Finance LLC reduced its stake in DuPont de Nemours by 65.7% in Q2, selling 10,483 shares. Meanwhile, DuPont reported strong Q2 earnings exceeding analyst estimates with a maintained Moderate
Qnity Electronics retains a $43 million indemnity liability linked to DuPont's North Carolina PFAS settlement per SEC filings. Despite covering 44% of DuPont's after-tax responsibility, Qnity reports
Chemours, DuPont, and Corteva agreed to a $455 million settlement over 15 years to resolve PFAS-related claims in North Carolina, with Chemours covering 50% of payments while allowing continued operat
Wellington Management Group LLP reduced its stake in DuPont de Nemours by 64.2%, selling 59,724 shares in Q2. DuPont also reported strong quarterly earnings, beating expectations with $1.88 EPS and de
Concurrent Investment Advisors LLC reduced its stake in DuPont de Nemours by 62.8% in Q2, while the company posted stronger-than-expected earnings and declared a $0.60 dividend.
TD Waterhouse Canada Inc. reduced its DuPont stake by 87.2% to $1.67 million in Q2. DuPont reported strong quarterly earnings beating estimates, with analysts maintaining a Moderate Buy rating.
Community Bank N.A. reduced its DuPont de Nemours stake by 67.2% in Q2, while other institutions increased holdings. The company beat earnings estimates with a Moderate Buy consensus and $166.60 targe
Mraz Amerine & Associates Inc. reduced its DuPont stake by 66.5% in Q2, while DuPont reported strong Q2 earnings with $1.88 adjusted EPS.
Greenleaf Trust reduced its DuPont de Nemours stake by 71.8% in Q2, selling 14,453 shares. DuPont also reported strong Q2 earnings with $1.88 EPS and announced a $0.60 quarterly dividend.
Addenda Capital Inc. reduced its stake in DuPont de Nemours by 66.7% in Q2, while the company beat earnings forecasts and declared a $0.60 quarterly dividend.
DuPont de Nemours Inc. shares fell 1.20% to close at $136.67 on Monday, marking three consecutive days of losses during a mixed trading session.
DuPont de Nemours Inc. reports a forward price-to-sales ratio on the BCBA exchange, with the market closed and no trades recorded at publication.
TradingView displays the forward price-to-sales ratio for DuPont de Nemours Inc., noting the market was closed with no trades reported at publication.
Simply Wall St analyzes DuPont de Nemours, highlighting valuation and growth prospects alongside new direct lithium extraction products and PFAS legal updates.
DuPont de Nemours stock outperformed the S&P 500 driven by growth in water treatment and biopharma processing. Analysts maintain a Strong Buy rating with significant upside potential.
RBC Capital lowered DuPont de Nemours' price target to $176 while maintaining an Outperform rating after Q2 2026 earnings showed revenue and earnings growth with updated guidance.
UBS raised its price target for DuPont de Nemours to $178 and maintained a Buy rating following strong second-quarter 2026 earnings and a raised full-year profit outlook.
DuPont reported better-than-expected Q2 2026 results with raised full-year guidance while actively exploring M&A opportunities in water and healthcare sectors. Additionally, the company announced plan
DuPont raised its annual profit forecast after exceeding second-quarter estimates, driven by price hikes and strategic cost cuts. The company successfully countered rising feedstock and energy costs a
DuPont de Nemours Inc shares rose 3.1% to $141.28, yet GuruFocus values indicate significant overvaluation with a forward P/E of 19.8x versus a 5-year median of 6.6x.
Lombard Odier Asset Management Europe Ltd reduced its stake in Corteva by 11.9% in Q1 2026, selling 22,426 shares. The adjustment occurs despite Corteva raising its fiscal 2026 EPS outlook following a
Analysts recommend a "Buy" trend for DuPont de Nemours Inc (DD) with an average price target of $46.12. The company expects next quarter revenue of $1.81 billion and EPS of $1.77.
Corteva Inc. authorized a $0.18 per share common stock dividend payable in September 2026, alongside preferred stock dividends from subsidiary EIDP Inc., reaffirming its role as a global agriculture s
Oppenheimer raised its price target for Corteva to $95 from $89 while maintaining an Outperform rating, reflecting analyst confidence in the agricultural chemicals company.
RBC Capital raised Corteva's price target to $103 from $97, maintaining an "Outperform" rating based on a positive outlook for the agricultural chemicals firm.
Investment analysts compare Dow Inc. and DuPont, favoring Dow for its valuation and earnings growth despite market challenges. Both chemical giants currently hold a Zacks Rank #3 Hold rating.
Mizuho raised its price target for agricultural chemicals firm Corteva to $97 from $96, maintaining an Outperform rating. This adjustment reflects a slightly more optimistic outlook on the company's f
DuPont de Nemours, Inc. displays its return on assets percentage on the Stuttgart Stock Exchange. Currently, the market is closed with no trades recorded on the platform.
DuPont de Nemours disclosed its free cash flow figures for the period, highlighting value and changes. This data point reflects the chemical giant's financial liquidity on the SWB platform.
International Flavors & Fragrances Inc. shares fell 5.1% to $77.68 amid a broad selloff in specialty chemicals, marking the steepest decline among peers due to sector-wide market pressures.
DuPont de Nemours executed a 1-for-3 reverse stock split and joined defensive indexes while pivoting to higher-value sectors. Forecasts indicate growth by 2029 despite ongoing PFAS litigation and regu
TradingView displays net margin percentage for DuPont de Nemours Inc., noting the market is closed with no trades.
The content displays the Price-to-Sales Forward metric for DuPont de Nemours Inc. on the Buenos Aires Stock Exchange. No specific numerical data is detailed in the provided text.
Financial data page displays book value per share for DuPont de Nemours (GETTEX:6D8), noting no trades have occurred on the platform.
DuPont de Nemours Inc. financial metrics page displays asset turnover data on the GETTEX platform. The report details period values and percentage changes for investor analysis.
Financial data and stock performance metrics for DuPont de Nemours Inc. are presented, highlighting market cap, P/E ratios, and dividends within the specialty chemicals sector.
Shares of TechnipFMC PLC rallied 1.23% to $65.23, outperforming major indices despite closing below its 52-week high.
Financial data for DuPont de Nemours Inc. preferred dividends (MUN:6D8) is tracked, though the market is currently closed with no trades. No specific dividend values or dates are provided in this entr
TradingView displays the forward price-to-sales metric for DuPont de Nemours, Inc., noting the market is currently closed with data sourced from ICE and FactSet.
DuPont de Nemours shares trade steadily following a 1-for-3 stock split, with Deutsche Bank reiterating a Buy rating amid strong technical momentum in the S&P 500 chemicals sector.
DuPont de Nemours' financial data page on TradingView currently lacks fundamental metrics like market capitalization and revenue. The company, established in 1802, continues to specialize in materials
DuPont de Nemours' forward price-to-book ratio is highlighted in a financial overview snapshot. This data point serves as a key metric for investors researching the chemical company.
ChemBrief